Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
554.3 USD | +4.45% | +4.70% | +17.51% |
07-15 | Truist Securities Adjusts Price Target on Elevance Health to $620 From $600, Maintains Buy Rating | MT |
07-11 | 50 billion dollars - What US insurers pocketed for fictitious illnesses |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.51% | 123B | |
+13.58% | 94.15B | |
-13.47% | 46.3B | |
-6.79% | 35.22B | |
-15.13% | 16.64B | |
-19.07% | 2.76B | |
+14.46% | 1.72B | |
+81.70% | 784M |
- Stock Market
- Equities
- ELV Stock
- News Elevance Health, Inc.
- Transcript : WellPoint Inc., Q4 2011 Earnings Call, Jan 25, 2012